IPP Bureau
GlaxoSmithkline Pharmaceuticals appoints Carson Dalton as Executive VP - Communications and Government Affairs
By IPP Bureau - March 04, 2025
Carson brings with him over two decades of experience in Communications, Public Affairs, and Sustainability
Biocon Academy conducts 9th Graduation Day
By IPP Bureau - March 04, 2025
Notably, 36 female students have been placed in Production and Manufacturing roles, reflecting the growing representation of women in core biotech operations
Senores Pharmaceuticals acquires 14 ANDAs from Dr. Reddy’s Laboratories
By IPP Bureau - March 04, 2025
The basket acquired, comprises of 13 ANDAs, which are approved by the USFDA and 1 ANDA, which is pending approval from the USFDA
Venus Remedies secures firstiInternational market authorization for Sugammadex from the Philippines
By IPP Bureau - March 04, 2025
The approval marks Venus Remedies’ strategic entry into complex generics, expanding its injectable portfolio beyond traditional formulations
Lilly plans to more than double US manufacturing investment since 2020 exceeding $50 billion
By IPP Bureau - March 03, 2025
Company expects to begin building four more domestic manufacturing sites this year and add 13,000 high-wage manufacturing and construction jobs in America
Glenmark Pharmaceuticals acquires and launches acetylcysteine injection
By IPP Bureau - March 03, 2025
Glenmark acquired the ANDA for Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials from Aspen Pharma USA
PMBJP has led to a total savings of Rs. 30,000 crore for citizens: Health Minister Nadda
By IPP Bureau - March 03, 2025
In financial year 2024-25, PMBJP has made sales of Rs. 1,760 crore (at MRP) till Feb 2025
WuXi XDC and LigaChem Biosciences expands MoU to accelerate ADC development
By IPP Bureau - March 03, 2025
WuXi XDC's fully integrated ADC discovery service platform will significantly boost the speed and efficiency of LigaChem's ADC development programs
Biocon launches GLP -1, Liraglutide, in UK
By IPP Bureau - March 01, 2025
The launch follows the approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), U.K.
Healthcare Triangle announces $15.2 million PIPE offering
By IPP Bureau - March 01, 2025
The PIPE offering consists of 36,190,476 units
Lupin secures a place in S&P Global Sustainability Yearbook 2025
By IPP Bureau - February 28, 2025
Yearbook members are selected basis their S&P Global 2024 Corporate Sustainability Assessment score
Cupid receives Rs. 42 crore order from Tanzania
By IPP Bureau - February 28, 2025
We have big plans across our B2C and B2B businesses in India and abroad
Sanofi India declares 8% growth in net sales for Q4-2024
By IPP Bureau - February 28, 2025
Standalone profit from operations for Q4-2024 were Rs. 108 crore
Biocon Foundation marks 20 years of transforming lives
By IPP Bureau - February 28, 2025
Biocon Foundation has been steadfast in its mission to empower underserved communities through innovative healthcare solutions, education, and sustainable development initiatives
Zydus Lifesciences to launch protection against new strain of influenza virus
By IPP Bureau - February 27, 2025
VaxiFlu-4 is being marketed by Zydus Vaxxicare-a division of the group focussing on preventives
